Here are relevant reports on : ai-animal-health-market
-
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) & Region - Global Forecast to 2026
The global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at US$0.43 billion in 2025, stood at US$0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of US$0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Viscosupplementation Market by Product (Single, Three, Five Injection), Application (knee, hip osteoarthritis), Source (animal, non-animal), End-user (Hospitals, Orthopedic Clinics/ASCs), Region (northamerica, Asia Pacific, Europe) - Forecast to 2027
The global Viscosupplementation market size is projected to reach USD XX million by 2027 from USD XX million in 2022, at a CAGR of XX% during the forecast period. The market is driven by factors such as the increasing global prevalence of osteoarthritis, the increasing geriatric population, and the rise in sports injuries. On the other hand, the high cost of products is expected to limit market growth to a certain extent in the coming years.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Riboflavin Market by Source (Plant and Animal), Form (Food & Beverages, Dietary Supplements, Pharmaceutical, Cosmetics & Personal Care, Animal Feed) and Region - Global Forecast to 2027
According to MarketsandMarkets, the global riboflavin market is estimated to be valued at USD 389.5 million in 2022 and is projected to reach USD 555.6 million by 2027. The market is expected to grow with a CAGR of 6.2%, in terms of value between 2022 and 2027. Riboflavin, or vitamin B2, assists many enzymes with multiple daily functions in the body. The market is majorly driven by increasing consumer awareness regarding health & wellness and rising demand for dietary supplements.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Lipase Market by Source (Microbial Lipases, Animal Lipases), Application (Animal Feed, Dairy, Bakery, Confectionery, Others), & by Geography (North America, Europe, Asia-Pacific, Latin America, RoW) - Global Forecast to 2020
Lipase is one of the rapidly growing markets in the industrial enzymes market, mainly due to its numerous health and industrial benefits. It helps in the digestion of fats by breaking them down into fatty acids and glycerol. It also helps in controlling appetite and regulates cholesterol levels in the body. The lipase market is projected to reach $590.5 Million by 2020, at a CAGR of 6.5% between 2015 and 2020.
- Published: September 2015
- Price: $ 4950
- TOC Available:
-
Probiotic Ingredients Market by Application (Functional Foods & Beverages, Pharmaceuticals, and Animal Nutrition), Source (Bacteria and Yeast), Form (Dry and Liquid), End User (Human and Animal), and Region - Global Forecast to 2023
The probiotic ingredients market is projected to grow from USD 268 million in 2018 to USD 402 million by 2023, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The increasing demand for dietary supplements in the pharmaceuticals, cosmetics, and personal care industries is projected to drive the market for probiotics, which in turn, is projected to drive the market growth for probiotic ingredients.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Animal Wound Care Market by Product (Surgical (Sutures & Staplers), Advanced (Foam, Hydrocolloid, Hydrogel), Traditional (Tapes, Bandages)), Animal Type (Companion, Livestock), Distribution Channel (Retail, E-Commerce), End User - Global Forecast to 2030
The global animal wound care market, valued at US$1.21 billion in 2024, stood at US$1.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.9% from 2024 to 2030, culminating in a forecasted valuation of US$1.79 billion by the end of the period. Several factors are driving the demand for animal wound care products, including the increasing adoption of pets, growing research in veterinary healthcare, and rising expenditures on animal healthcare
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
